nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Hypoxemia—Methotrexate—stomach cancer	0.0499	0.0499	CcSEcCtD
Cisatracurium Besylate—Erythema—Floxuridine—stomach cancer	0.0258	0.0258	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Floxuridine—stomach cancer	0.021	0.021	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Floxuridine—stomach cancer	0.0206	0.0206	CcSEcCtD
Cisatracurium Besylate—Erythema—Mitomycin—stomach cancer	0.0202	0.0202	CcSEcCtD
Cisatracurium Besylate—Azotaemia—Methotrexate—stomach cancer	0.0188	0.0188	CcSEcCtD
Cisatracurium Besylate—Hypertension—Mitomycin—stomach cancer	0.0175	0.0175	CcSEcCtD
Cisatracurium Besylate—Injury—Irinotecan—stomach cancer	0.0159	0.0159	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Methotrexate—stomach cancer	0.0158	0.0158	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Floxuridine—stomach cancer	0.0155	0.0155	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Irinotecan—stomach cancer	0.0151	0.0151	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Mitomycin—stomach cancer	0.0147	0.0147	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Irinotecan—stomach cancer	0.0139	0.0139	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Fluorouracil—stomach cancer	0.0133	0.0133	CcSEcCtD
Cisatracurium Besylate—Rash—Floxuridine—stomach cancer	0.0133	0.0133	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Floxuridine—stomach cancer	0.0133	0.0133	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Fluorouracil—stomach cancer	0.0123	0.0123	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Epirubicin—stomach cancer	0.0107	0.0107	CcSEcCtD
Cisatracurium Besylate—Rash—Mitomycin—stomach cancer	0.0104	0.0104	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Mitomycin—stomach cancer	0.0104	0.0104	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Irinotecan—stomach cancer	0.0103	0.0103	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Irinotecan—stomach cancer	0.00992	0.00992	CcSEcCtD
Cisatracurium Besylate—Cardiovascular disorder—Doxorubicin—stomach cancer	0.00987	0.00987	CcSEcCtD
Cisatracurium Besylate—Flushing—Irinotecan—stomach cancer	0.00937	0.00937	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Capecitabine—stomach cancer	0.00928	0.00928	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Irinotecan—stomach cancer	0.00916	0.00916	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Irinotecan—stomach cancer	0.00911	0.00911	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Irinotecan—stomach cancer	0.00909	0.00909	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Capecitabine—stomach cancer	0.00861	0.00861	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Docetaxel—stomach cancer	0.00857	0.00857	CcSEcCtD
Cisatracurium Besylate—Erythema—Fluorouracil—stomach cancer	0.00841	0.00841	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Capecitabine—stomach cancer	0.0083	0.0083	CcSEcCtD
Cisatracurium Besylate—Hypertension—Irinotecan—stomach cancer	0.00758	0.00758	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methotrexate—stomach cancer	0.00751	0.00751	CcSEcCtD
Cisatracurium Besylate—Convulsion—Fluorouracil—stomach cancer	0.00729	0.00729	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Irinotecan—stomach cancer	0.00717	0.00717	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Irinotecan—stomach cancer	0.00703	0.00703	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Epirubicin—stomach cancer	0.00703	0.00703	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Capecitabine—stomach cancer	0.00688	0.00688	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Fluorouracil—stomach cancer	0.00687	0.00687	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Docetaxel—stomach cancer	0.00685	0.00685	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Fluorouracil—stomach cancer	0.00673	0.00673	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Fluorouracil—stomach cancer	0.0067	0.0067	CcSEcCtD
Cisatracurium Besylate—Hypotension—Irinotecan—stomach cancer	0.0067	0.0067	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Capecitabine—stomach cancer	0.00664	0.00664	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.0065	0.0065	CcSEcCtD
Cisatracurium Besylate—Flushing—Docetaxel—stomach cancer	0.00647	0.00647	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Epirubicin—stomach cancer	0.00647	0.00647	CcSEcCtD
Cisatracurium Besylate—Hypotension—Fluorouracil—stomach cancer	0.00642	0.00642	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Irinotecan—stomach cancer	0.00639	0.00639	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Docetaxel—stomach cancer	0.00633	0.00633	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Docetaxel—stomach cancer	0.0063	0.0063	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Docetaxel—stomach cancer	0.00629	0.00629	CcSEcCtD
Cisatracurium Besylate—Flushing—Capecitabine—stomach cancer	0.00627	0.00627	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Capecitabine—stomach cancer	0.00613	0.00613	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Fluorouracil—stomach cancer	0.00612	0.00612	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Capecitabine—stomach cancer	0.0061	0.0061	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Capecitabine—stomach cancer	0.00609	0.00609	CcSEcCtD
Cisatracurium Besylate—Erythema—Docetaxel—stomach cancer	0.00607	0.00607	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Epirubicin—stomach cancer	0.006	0.006	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Doxorubicin—stomach cancer	0.00598	0.00598	CcSEcCtD
Cisatracurium Besylate—Erythema—Capecitabine—stomach cancer	0.00588	0.00588	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Doxorubicin—stomach cancer	0.00555	0.00555	CcSEcCtD
Cisatracurium Besylate—Urticaria—Fluorouracil—stomach cancer	0.00545	0.00545	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Irinotecan—stomach cancer	0.00528	0.00528	CcSEcCtD
Cisatracurium Besylate—Convulsion—Docetaxel—stomach cancer	0.00526	0.00526	CcSEcCtD
Cisatracurium Besylate—Hypertension—Docetaxel—stomach cancer	0.00524	0.00524	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00513	0.00513	CcSEcCtD
Cisatracurium Besylate—Hypertension—Capecitabine—stomach cancer	0.00508	0.00508	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Fluorouracil—stomach cancer	0.00506	0.00506	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00497	0.00497	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Docetaxel—stomach cancer	0.00496	0.00496	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Docetaxel—stomach cancer	0.00486	0.00486	CcSEcCtD
Cisatracurium Besylate—Pruritus—Fluorouracil—stomach cancer	0.00486	0.00486	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Docetaxel—stomach cancer	0.00484	0.00484	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Docetaxel—stomach cancer	0.00481	0.00481	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Epirubicin—stomach cancer	0.00479	0.00479	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Capecitabine—stomach cancer	0.00471	0.00471	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Capecitabine—stomach cancer	0.00468	0.00468	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Capecitabine—stomach cancer	0.00466	0.00466	CcSEcCtD
Cisatracurium Besylate—Hypotension—Docetaxel—stomach cancer	0.00463	0.00463	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Epirubicin—stomach cancer	0.00462	0.00462	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methotrexate—stomach cancer	0.00456	0.00456	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methotrexate—stomach cancer	0.00454	0.00454	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methotrexate—stomach cancer	0.00453	0.00453	CcSEcCtD
Cisatracurium Besylate—Rash—Irinotecan—stomach cancer	0.00452	0.00452	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Irinotecan—stomach cancer	0.00452	0.00452	CcSEcCtD
Cisatracurium Besylate—Hypotension—Capecitabine—stomach cancer	0.00448	0.00448	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Doxorubicin—stomach cancer	0.00443	0.00443	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Docetaxel—stomach cancer	0.00442	0.00442	CcSEcCtD
Cisatracurium Besylate—Erythema—Methotrexate—stomach cancer	0.00438	0.00438	CcSEcCtD
Cisatracurium Besylate—Flushing—Epirubicin—stomach cancer	0.00437	0.00437	CcSEcCtD
Cisatracurium Besylate—Rash—Fluorouracil—stomach cancer	0.00433	0.00433	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Fluorouracil—stomach cancer	0.00433	0.00433	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Doxorubicin—stomach cancer	0.00428	0.00428	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Capecitabine—stomach cancer	0.00428	0.00428	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Epirubicin—stomach cancer	0.00427	0.00427	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Epirubicin—stomach cancer	0.00425	0.00425	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Epirubicin—stomach cancer	0.00424	0.00424	CcSEcCtD
Cisatracurium Besylate—Erythema—Epirubicin—stomach cancer	0.0041	0.0041	CcSEcCtD
Cisatracurium Besylate—Flushing—Doxorubicin—stomach cancer	0.00404	0.00404	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Doxorubicin—stomach cancer	0.00395	0.00395	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Doxorubicin—stomach cancer	0.00393	0.00393	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Doxorubicin—stomach cancer	0.00392	0.00392	CcSEcCtD
Cisatracurium Besylate—Urticaria—Capecitabine—stomach cancer	0.00381	0.00381	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methotrexate—stomach cancer	0.00379	0.00379	CcSEcCtD
Cisatracurium Besylate—Erythema—Doxorubicin—stomach cancer	0.00379	0.00379	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.0037	0.0037	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Docetaxel—stomach cancer	0.00365	0.00365	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methotrexate—stomach cancer	0.00357	0.00357	CcSEcCtD
Cisatracurium Besylate—Convulsion—Epirubicin—stomach cancer	0.00355	0.00355	CcSEcCtD
Cisatracurium Besylate—Hypertension—Epirubicin—stomach cancer	0.00354	0.00354	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Capecitabine—stomach cancer	0.00354	0.00354	CcSEcCtD
Cisatracurium Besylate—Pruritus—Docetaxel—stomach cancer	0.00351	0.00351	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methotrexate—stomach cancer	0.0035	0.0035	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methotrexate—stomach cancer	0.00347	0.00347	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00346	0.00346	CcSEcCtD
Cisatracurium Besylate—Pruritus—Capecitabine—stomach cancer	0.00339	0.00339	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Epirubicin—stomach cancer	0.00334	0.00334	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methotrexate—stomach cancer	0.00334	0.00334	CcSEcCtD
Cisatracurium Besylate—Convulsion—Doxorubicin—stomach cancer	0.00328	0.00328	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Epirubicin—stomach cancer	0.00328	0.00328	CcSEcCtD
Cisatracurium Besylate—Hypertension—Doxorubicin—stomach cancer	0.00327	0.00327	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Epirubicin—stomach cancer	0.00326	0.00326	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Epirubicin—stomach cancer	0.00325	0.00325	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.0032	0.0032	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Methotrexate—stomach cancer	0.00318	0.00318	CcSEcCtD
Cisatracurium Besylate—Rash—Docetaxel—stomach cancer	0.00312	0.00312	CcSEcCtD
Cisatracurium Besylate—Hypotension—Epirubicin—stomach cancer	0.00312	0.00312	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Docetaxel—stomach cancer	0.00312	0.00312	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Doxorubicin—stomach cancer	0.00309	0.00309	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Doxorubicin—stomach cancer	0.00303	0.00303	CcSEcCtD
Cisatracurium Besylate—Rash—Capecitabine—stomach cancer	0.00303	0.00303	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Capecitabine—stomach cancer	0.00302	0.00302	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Doxorubicin—stomach cancer	0.00302	0.00302	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Doxorubicin—stomach cancer	0.003	0.003	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Epirubicin—stomach cancer	0.00298	0.00298	CcSEcCtD
Cisatracurium Besylate—Hypotension—Doxorubicin—stomach cancer	0.00289	0.00289	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methotrexate—stomach cancer	0.00284	0.00284	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Doxorubicin—stomach cancer	0.00276	0.00276	CcSEcCtD
Cisatracurium Besylate—Urticaria—Epirubicin—stomach cancer	0.00266	0.00266	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methotrexate—stomach cancer	0.00263	0.00263	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methotrexate—stomach cancer	0.00253	0.00253	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Epirubicin—stomach cancer	0.00246	0.00246	CcSEcCtD
Cisatracurium Besylate—Urticaria—Doxorubicin—stomach cancer	0.00246	0.00246	CcSEcCtD
Cisatracurium Besylate—Pruritus—Epirubicin—stomach cancer	0.00237	0.00237	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Doxorubicin—stomach cancer	0.00228	0.00228	CcSEcCtD
Cisatracurium Besylate—Rash—Methotrexate—stomach cancer	0.00225	0.00225	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methotrexate—stomach cancer	0.00225	0.00225	CcSEcCtD
Cisatracurium Besylate—Pruritus—Doxorubicin—stomach cancer	0.00219	0.00219	CcSEcCtD
Cisatracurium Besylate—Rash—Epirubicin—stomach cancer	0.00211	0.00211	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Epirubicin—stomach cancer	0.00211	0.00211	CcSEcCtD
Cisatracurium Besylate—Rash—Doxorubicin—stomach cancer	0.00195	0.00195	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Doxorubicin—stomach cancer	0.00195	0.00195	CcSEcCtD
